Editor's take: The week that was — Dec 12-17
This is the last edition of the weekly wrap for this year.
Stay updated with breaking news from Blue Future Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This is the last edition of the weekly wrap for this year.
The firm plans to increase exposure to APAC in the coming years.
2021 was a record year for venture capital (VC) investments in Vietnam, driven by a maturing technology startup ecosystem, an increasing number of later stage investments, and rising participation from both local and foreign investors eager to tap into Vietnam’s burgeoning digital economy, a new report by Silverhorn says.
The fund is aiming to build the next wave of globally iconic startups emerging from Vietnam.
China Digest: Biopharma startup Alebund raises $60m; Revere VC closes seed round May 11, 2021 Chinese biopharmaceutical startup Alebund Pharmaceuticals has secured $60 million in a Series B round, while San Francisco and Hong Kong-based asset management firm Revere VC has closed its seed round. Alebund Pharma nets $60m in Series B round Alebund Pharmaceuticals, a biopharmaceutical startup that develops innovative therapies for the treatment of renal diseases, has bagged $60 million in a Series B round of financing, the startup announced on May 9. The Series B round was led by Quan Capital, a...